In addition, BCR-ABL may function as a key factor to stimulate mTOR transcription in chronic myeloid leukemia (CML) through PI3KCI-Akt-FOXO signaling (Kang et al., 2011). This evidence concerns the gene MTOR and chronic myelogenous leukemia, BCR-ABL1 positive.